Staying Alive is reader supported. When you buy through our links, we may earn a commission. Learn More >

The LDN Book, Volume Two

The Latest Research on How Low Dose Naltrexone Could Revolutionize Treatment for PTSD, Pain, IBD, Lyme Disease, Dermatologic Conditions, and More

Profile picture of linda-elsegood Linda Elsegood (Author)
Oct 09, 2020 | 288 Pages
The LDN Book Volume Two

The medical and scientific communities are thrilled to have uncovered Low-Dose Naltrexone (LDN) - a drug that is cost-effective, free of major side effects, and suitable for treating numerous illnesses.

LDN stands out amongst modern pharmaceuticals because it offers an unparalleled combination of advantages.

LDN, which was initially prescribed in high doses as a therapy for opioid dependency, functions by blocking opioid receptors and enjoying the production of endorphins. This helps alleviate inflammation while also stabilizing your immune system response.

By prescribing this generic drug off-label and administering it in small doses, physicians have seen remarkable results when treating a variety of illnesses.

The LDN Book, Volume 2 provides readers with the newest clinical trials, case studies, and research about how Low Dose Naltrexone (LDN) can help treat conditions like lupus, thyroiditis, autism spectrum disorder, and chronic fatigue.

Numerous medical professionals share their insights on using LDN to assist patients plagued by a range of debilitating illnesses in this updated edition which builds upon the previous volume's trailblazing findings.

From aches and pains to Lyme disease, utilizing innovative strategies for managing chronic pain, Parkinson's Disease, dermatologic conditions, traumatic brain injury, and beyond.

The LDN Book, Volume 2 is not only a guidebook for practitioners, pharmacists, and patients but also an urgent appeal to conduct additional research into the healing capabilities of generic drugs.

Related Books

All Related Books